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ABSTRACT
Identification of an HLA identical donor/recipient pair using high-resolution techniques at HLA A, B, C, and
DRB1 optimizes survival after adult unrelated hematopoietic stem cell transplant. It has been estimated that
roughly 50% of African-Americans have suitable unrelated donors based on serologic typing, but there is little
information on the likelihood of identifying an HLA-identical unrelated donor using molecular techniques.
From February 2002 to May 2007, we performed 51 unrelated donor searches for African-American patients
using the National Marrow Donor Program and found HLA identical unrelated donors for only 3. By contrast,
50 (98%) had at least 1, and often multiple, appropriately matched cord blood units available. Very few African-
American recipients haveHLA-identical unrelated donors. To allowmore African-American patients to proceed
to transplant, innovative donor strategies, including adult cord blood transplantation, haploidentical transplant,
or the identification of permissive mismatches should be investigated.
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Formany hematologic disorders, allogeneic hema-
topoietic stem cell transplant represents the best
chance for long-term survival. Only 25% to 30% of
patients have HLA-identical sibling donors [1], and
the likelihood is even lower for patients of African-
American descent [2]. Therefore, the majority of pa-
tients require an alternative donor source, usually
from an unrelated adult or cord blood donor. For
more than 20 years, the National Marrow Donor Pro-
gram (NMDP) has been recruiting volunteer donors
for patients without an HLA identical sibling [1,3].
The identification of a donor matched at HLA-A, B,
C, and DRB1 is important for the success of adult
unrelated donor transplantation, because each HLA
mismatch decreases overall survival by nearly 10%
in patients with early-stage disease [4]. Even after
adjusting for HLA-mismatch at the major HLA loci,938African-Americans have a 50% increased risk of death
after hematopoietic stem cell transplantation [4]. This
heightens the importance of finding a match at all 8
loci by high-resolution HLA typing.
There are approximately 510,000 registered Afri-
can-American adult donors within the NMDP regis-
try, compared to more than 5 million Caucasians [3].
African-Americans also have a high degree of polymor-
phism with respect to the major HLA loci compared
to other populations [5,6]. Although it is thought
that suitable donors can be identified for 50% of Afri-
can-Americans, such estimates are based on serologic
typing [7]. In this study, we sought to establish the like-
lihood of identifying an HLA-identical 8/8 unrelated
donor, as well as alternative donor sources, including
single antigen or allele mismatched unrelated donors
and umbilical cord blood units in African-American
patients treated at the University of Chicago.
Paucity of Unrelated Donors for African-Americans 939Table 1. Unrelated Donor (URD) Searches for African-Americans with Hematologic Malignancies
Potential URD
HLA Match Level
Preliminary Search:
Number of Patients
with Potential URD
Number of Patients
with Formal Search
Number of
Patients with
8/8 URD
Number of
Patients with
7/8 URD
Number of
Patients with
\7/8 URD
Patients
Transplanted
with the URD
6/6 13 12 3 2 7 2
5/6 37 24 8 16 1
\5/6 1
Total 51 36 3 10 23 3MATERIALS AND METHODS
From February 2002 to May 2007, the University
of Chicago, an NMDP-approved transplant center,
performed 51 preliminary unrelated donor searches
for African-American patients using the NMDP and
its cooperative international registries. All preliminary
searches were repeated between May 2007 and Febru-
ary 2008 to test the NMDP registry donor pool at its
current level.
Umbilical cord blood unit preliminary searches
only considered cord blood units available from the
NMDP. Cord blood unit cell doses were calculated us-
ing the cord blood unit with the largest total nucleated
cell count. Cord blood unit HLA match was deter-
mined by the current accepted cord blood criteria of
low resolution at HLA-A and B, and high resolution
at HLA-DRB1 [8].
High-resolution HLA typing of donor/recipient
pairs at HLA-A, B, C, and DRB1 was used to identify
the most suitable donors. All formal unrelated donor
searches were reviewed weekly by the transplant
team, consisting of the transplant physicians, the trans-
plant coordinator, and data management personnel.
This retrospective analysis of unrelated donor and
cord blood searches for African-Americans was ap-
proved by the University of Chicago institutional
review board.
RESULTS
The median age of the 51 African-American
patientswas 38years (range: 1-73), anddiseases included
AML (n 5 18), myelodysplastic syndromes (n 5 1),
ALL (n 5 1), CLL (n 5 4), CML (n 5 4), Hodgkin
lymphoma (n 5 4), NHL (n 5 4), multiple myeloma
(n 5 1), severe aplastic anemia (n 5 4), sickle cell ane-
mia (n5 6), and other (n5 4). Thirteen (25%) patientshadpotential low-resolutionHLA-A,B, andDRB1 (6/6)
unrelated donors, 37 (73%) patients had potential
donors with a single allele or antigen mismatch at
HLA-A, B, or DRB1 (5/6), and 1 patient had only
potential 4/6 donors.
All unrelated donor searches are summarized in
Table 1. In total, 275 donors were activated, and 133
were unavailable for confirmatory typing (48%).
There were 13 patients with potential 6/6 donors
from the preliminary search; 12 proceeded to a formal
search for confirmatory high-resolution HLA typing.
After a median formal search duration of 5 months
(range: 1-39), 3 patients were found to have an unre-
lated donor who wasHLA identical by high-resolution
typing at all loci (ie, 8/8 match), and 2 patients were
found to have a donor with a single allele or antigen
mismatch (ie, 7/8 match). Because it can be assumed
that only a 6/6 unrelated donor will yield an 8/8 donor,
only 6% (3/51) of our African-American patients had
an 8/8 unrelated donor (25% of formal searches with
6/6). Two of the 3 patients with an 8/8 HLA identical
unrelated donor proceeded to transplant with that
donor.
Twenty-four of the 37 African-American patients
with a potential 5/6 unrelated donor proceeded to for-
mal unrelated donor search. Themedian formal search
duration for this groupwas also 5months (range: 1-29).
Eight patients were found to have a high-resolution
7/8 unrelated donor (33% of formal searches with
5/6), but only 1 proceeded to hematopoietic stem
cell transplant using this donor. Four did not pro-
ceed to transplant due to disease progression. The
other 3 patients were offered a different therapy or
donor strategy.
A retrospective preliminary search for unrelated
cord blood units yielded at least 1 and often several
(median: 14, range: 1-158) suitable potential 4/6 cordTable 2. Preliminary Cord Blood Unit Searches for African-Americans with Hematologic Malignancies
Potential HLA Match Grade
by Cord Blood Criteria
Number of Patients
with Cord Blood Units (%) Median Cell Dose
Percentage of Cord Blood Units
used for Median Cell Dose
with Confirmatory HLA
6/6 3 (6) 1.65  10(7)/kg
5/6 29 (57) 1.88  10(7)/kg 34 (10/29)
4/6 50 (98) 2.85  10(7)/kg 52 (26/50)
\4/6 1 (2)
940 A. Dew et al.blood units for 50 of 51 (98%) patients. One patient
had only potential 3/6 cord blood units. The median
cell dose for patients with potential 4/6 cord blood
units was 2.85  107/kg. Fifty-two percent (26/50) of
the 4/6 cord blood units used to determine median
cell dose had already been confirmatory HLA typed
and were verified 4/6 cords by cord blood criteria.
Twenty-nine (57%) patients had at least 1 (median:
1, range: 1-10) potential 5/6 cord blood unit, and 3
had at least 1 potential 6/6 cord blood unit. The
median cell dose for patients with potential 5/6 and
6/6 cord blood units was 1.88  107 /kg and 1.65 
107 /kg, respectively. Thirty-four percent (10/29) of
the 5/6 cord blood units used to determine median
cell dose were confirmatory HLA typed. No potential
6/6 cord blood units had been previously typed. Pre-
liminary cord blood unit searches are summarized in
Table 2.
DISCUSSION
Over the past decade it has been convincingly
shown that the identification of an HLA identical
donor/recipient pair using high-resolution techniques
at A, B, C, and DRB1 optimizes survival after adult
unrelated hematopoietic stem cell transplant [4,9].
Our data illustrate the low likelihood of locating
a matched unrelated donor for patients of African-
American descent. Given the high frequency of rare
and uncommon polymorphisms in the African-Amer-
ican population, increasing the donor pool seems un-
likely to enhance the odds of finding a suitable adult
unrelated donor [5,6,9]. Efforts that allow transplan-
tation across HLA-barriers may be a better option
to improve hematopoietic stem cell transplant acces-
sibility. The wide availability and speedy acquisition
of unrelated umbilical cord blood units creates an at-
tractive resource for patients without an appropriate
unrelated donor [10-12]. Our data show an abun-
dance of unrelated cord blood units available for
our African-American patients within the NMDP
registry. It is likely that many additional suitable
cords for African-American patients exist within other
domestic and international cord blood registries.
Although the majority of identified units were only
4/6 matched, previous studies have shown promising
results using such units, with cell doses comparable to
our data, in adult and pediatric populations [8,12,13].
Whether or not umbilical cord blood transplantation
will be equally permissive with respect to HLA dis-
parity for African-American adults requires further
study. Other strategies of interest include haploident-
ical transplantation [14,15], the combination of a hap-
loidentical donor and single cord blood unit [16], as
well as efforts to identify permissive HLA mismatches
in recipients of unrelated donor transplantation
[17,18].ACKNOWLEDGMENTS
Dr. van Besien was partially supported by NCI
Grant K24 CA116471-01.
REFERENCES
1. McCullough J, Perkins HA, Hansen J. The National Marrow
Donor Program with emphasis on the early years. Transfusion.
2006;46:1248-1255.
2. Aplenc R, Alonzo TA, Gerbing RB, et al. Ethnicity and survival
in childhood acute myeloid leukemia: a report from the Chil-
dren’s Oncology Group. Blood. 2006;108:74-80.
3. National Marrow Donor Program: Facts and Figures. 2007;
http://www.marrow.org/NEWS/MEDIA/Facts_and_Figures/
facts_figures.pdf. Accessed February 15, 2008.
4. Lee SJ, Klein J, Haagenson M, et al. High-resolution donor-re-
cipient HLA matching contributes to the success of unrelated
donor marrow transplantation. Blood. 2007;110:4576-4583.
5. Beatty PG, Mori M, Milford EL. Impact of racial genetic poly-
morphism on the probability of finding anHLA-matched donor.
Transplant. 1995;60:778-783.
6. Kuffner T,WhitworthW, JairamM,McNicholl J. HLA class II
and TNF genes in African Americans from the Southeastern
United States: regional differences in allele frequencies. Hum
Immunol. 2003;64:639-647.
7. Krishnamurti L, Abel S, Maiers M, Flesch S. Availability of
unrelated donors for hematopoietic stem cell transplantation
for hemoglobinopathies. Bone Marrow Transplant. 2003;31:
547-550.
8. Eapen M, Rubinstein P, Zhang MJ, et al. Outcomes of trans-
plantation of unrelated donor umbilical cord blood and bone
marrow in children with acute leukaemia: a comparison study.
Lancet. 2007;369:1947-1954.
9. Hurley CK, Baxter Lowe LA, Logan B, et al. National Marrow
Donor Program HLA-matching guidelines for unrelated
marrow transplants. Biol Blood Marrow Transplant. 2003;9:
610-615.
10. Hurley CK, Wagner JE, Setterholm MI, Confer DL.
Advances in HLA: practical implications for selecting adult
donors and cord blood units. Biol Blood Marrow Transplant.
2006;12:28-33.
11. Barker JN, Krepski TP, DeFor TE, Davies SM, Wagner JE,
Weisdorf DJ. Searching for unrelated donor hematopoietic
stem cells: availability and speed of umbilical cord blood ver-
sus bone marrow. Biol Blood Marrow Transplant. 2002;8:
257-260.
12. Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-
cord blood or bone marrow from unrelated donors in adults
with acute leukemia. N Engl J Med. 2004;351:2276-2285.
13. Brunstein CG, Barker JN, Weisdorf DJ, et al. Umbilical cord
blood transplantation after nonmyeloablative conditioning:
impact on transplantation outcomes in 110 adults with hemato-
logic disease. Blood. 2007;110:3064-3070.
14. BethgeWA, Faul C, BornhauserM, et al. Haploidentical alloge-
neic hematopoietic cell transplantation in adults using
CD3/CD19 depletion and reduced intensity conditioning: an
update. Blood Cells Mol Dis. 2008;40:13-19.
15. Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk
acute leukemia with T-cell depleted stem cells from related
donors with one fully mismatched HLA haplotype. N Engl J
Med. 1998;339:1186-1193.
Paucity of Unrelated Donors for African-Americans 94116. Magro E, Regidor C, Cabrera R, et al. Early hematopoietic
recovery after single unit unrelated cord blood transplantation
in adults supported by co-infusion of mobilized stem cells
from a third party donor. Haematology. 2006;91:640-648.
17. Kawase T, Morishima Y, Matsuo K, et al. High-risk HLA allele
mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mecha-
nism. Blood. 2007;110:2235-2241.
18. Heemskerk MB, Cornelissen JJ, Roelen DL, et al. Highly
diverged MHC class I mismatches are acceptable for haemato-
poietic stem cell transplantation. Bone Marrow Transplant.
2007;40:193-200.
